Loss of tumor HLA class I and PD-L1 expression in bladder cancer is associated with higher tumor grade and poor survival prognosis

被引：0
|
作者：
Gil-Julio, Hernani [1 ]
Perea, Francisco [2 ]
Torres, Cristina [1 ]
Manuel Cozar, Jose [1 ]
Garrido, Federico [3 ]
Aptsiauri, Natalia [3 ]
Ruiz-Cabello, Francisco [3 ]
机构：
[1] Hosp Univ Virgen de las Nieves, Granada, Spain
[2] IBS Granada, Granada, Spain
[3] Univ Granada, Granada, Spain
来源：
HLA | 2022年 / 99卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
O69
引用
收藏
页码：448 / 449
页数：2
相关论文
共 50 条
  • [1] PD-L1 tumor expression is associated with poor prognosis and systemic immunosuppression in glioblastoma
    Noronha, Carolina
    Ribeiro, Ana Sofia
    Taipa, Ricardo
    Leitao, Dina
    Schmitt, Fernando
    Reis, Joaquim
    Faria, Claudia
    Paredes, Joana
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2022, 156 (03) : 453 - 464
  • [2] PD-L1 tumor expression is associated with poor prognosis and systemic immunosuppression in glioblastoma
    Carolina Noronha
    Ana Sofia Ribeiro
    Ricardo Taipa
    Dina Leitão
    Fernando Schmitt
    Joaquim Reis
    Cláudia Faria
    Joana Paredes
    [J]. Journal of Neuro-Oncology, 2022, 156 : 453 - 464
  • [3] The Effects of Epigenetic Modifiers on PD-L1 and HLA Class I Expression on Tumor Cells
    Maini, Trisha
    Sternberg, Lauren
    O'Donnell, Robert W.
    [J]. FASEB JOURNAL, 2019, 33
  • [4] Loss of SMAD4 Is Associated With Poor Tumor Immunogenicity and Reduced PD-L1 Expression in Pancreatic Cancer
    Principe, Daniel R.
    Underwood, Patrick W.
    Kumar, Sandeep
    Timbers, Kaytlin E.
    Koch, Regina M.
    Trevino, Jose G.
    Munshi, Hidayatullah G.
    Rana, Ajay
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [5] Role of tumor-associated macrophages in esophageal cancer: PD-L1 expression and prognosis
    Yagi, Taisuke
    Baba, Yoshifumi
    Koga, Yuki
    Uchihara, Tomoyuki
    Kiyozumi, Yuki
    Sawayama, Hiroshi
    Hiyoshi, Yukiharu
    Iwatsuki, Masaaki
    Miyamoto, Yuji
    Yoshida, Naoya
    Baba, Hideo
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [6] HLA-class-I expression loss, tumor microenvironment and breast cancer prognosis
    Giatromanolaki, Alexandra
    Michos, Georgios D.
    Xanthopoulou, Erasmia
    Koukourakis, Michael I.
    [J]. CELLULAR IMMUNOLOGY, 2024, 399
  • [7] PD-L1 on Circulating Tumor Cells Indicates Poor Prognosis in Breast Cancer
    Wang, Xue-fei
    Zhang, Guo-chao
    Wu, Sha-fei
    Li, Jia-xin
    Sun, Qiang
    [J]. CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2022, 49 (11):
  • [8] Loss of tumor HLA class I expression in bladder cancer is associated with T cell exclusion and stromal changes
    Perea, Francisco
    Gil-Julio, Hernani
    Diaz, Irene
    Manuel Cozar, Jose
    Concha, Angel
    Garrido, Federico
    Aptsiauri, Natalia
    Ruiz-Cabello, Francisco
    [J]. HLA, 2022, 99 (05) : 542 - 543
  • [9] Urine PD-L1 is a tumor tissue candidate substitute and is associated with poor survival in muscle-invasive bladder cancer patients
    Ma, Jialu
    Zhou, Quan
    Xu, Wenbin
    Li, Chuangui
    Wang, Haicheng
    Zhai, Zhao
    Zhang, Yong
    Wahafu, Wasilijiang
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 114
  • [10] Expression of PD-L1 in tumor-associated nerves correlates with reduced CD8+ tumor-associated lymphocytes and poor prognosis in prostate cancer
    Mo, Ru-Jun
    Han, Zhao-Dong
    Liang, Ying-Ke
    Ye, Jian-Heng
    Wu, Shu-Lin
    Lin, Sharron X.
    Zhang, Yan-Qiong
    Song, Sheng-Da
    Jiang, Fu-Neng
    Zhong, Wei-De
    Wu, Chin-Lee
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (12) : 3099 - 3110
12345